We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

关于PEDI ANESTH - Trial

根据其账面婴儿和儿童麻醉中的实践一个计算器

# The Trial version will let you try full features of this app for 3 days #

This phone app is a welcome addition to the textbook A Practice of Anesthesia for

Infants and Children, Elsevier, Inc (by Charles J. Coté, Jerrold Lerman and Brian Anderson).

The app includes a quick drug calculator for most pediatric anesthesia and critical

care medications (including antibiotics, sedatives and local anesthetics), management

of emergency situations including anaphylaxis, cardiopulmonary resuscitation,

difficult airway algorithms, and malignant hyperthermia, as well as diagrams of all

major congenital heart lesions complete with bullet points for their anesthesia related

management. In addition, guidelines for blood component therapy, dosing of inotropes

, diagnosis and management of diabetes insipidus, endotracheal tube size based on age

and much more important information is included. This advanced app version will be

updated approximately every 6 months with exciting new data, tables and diagrams.

This very user-friendly design and interface of the advanced app presents a trove of valuable clinical information for the practitioner comes in 3 different versions.

The TRIAL version will let you try the full features of this app for 3 days.

The LITE version includes the Pocket Reference guide from the textbook which will never expire and allows access to the Pro version features for a limited time.

The PRO version comes with full features and unlimited time access to new updates.

最新版本1.3更新日志

Last updated on 2015年11月03日

- Minor UI change

翻译中...

更多应用信息

最新版本

请求 PEDI ANESTH - Trial 更新 1.3

上传者

Dharmesh Chunara

系统要求

Android 2.2+

更多

PEDI ANESTH - Trial 屏幕截图

订阅APKPure
第一时间获取热门安卓游戏应用的首发体验,最新资讯和玩法教程。
不,谢谢
订阅
订阅成功!
您已订阅APKPure。
订阅APKPure
第一时间获取热门安卓游戏应用的首发体验,最新资讯和玩法教程。
不,谢谢
订阅
成功!
您已订阅我们的邮件通知。